Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€45.00

€45.00

3.640%
1.6
3.640%
€51.52
 
03.06.25 / Tradegate WKN: A2AP32 / Symbol: PTGX / Name: Protagonist / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

Protagonist Therapeutics Inc Stock

A very strong showing by Protagonist Therapeutics Inc today, with an increase of €1.60 (3.640%) compared to yesterday's price.
The stock is one of the favorites of our community with 26 Buy predictions and 1 Sell predictions.
With a target price of 51 € there is a slightly positive potential of 13.33% for Protagonist Therapeutics Inc compared to the current price of 45.0 €.
So far the community has only identified positive things for Protagonist Therapeutics Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Protagonist Therapeutics Inc in the next few years

Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 0.90%
Target price 70.008
Change
Ends at 03.06.26

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Show more

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 7.66%
Target price 71.584
Change
Ends at 19.05.26

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Show more